Showing results (1541-1550 of 6,509) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|October 18, 2023
Apolipoprotein C-III itself stimulates the Syk/cPLA2-induced inflammasome activation of macrophage to boost anti-tumor activity of CD8+ T cellXiangyu Hu, Shizhen Ding, Guotao Lu, et al.Cancer Immunology, Immunotherapy : CII|October 17, 2023
Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptorDerrick McCarthy, Michael Lofgren, Amy Watt, et al.Cancer Immunology, Immunotherapy : CII|October 3, 2023
Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysisJiashuo Chao, Shanshan Wang, Hao Wang, et al.Cancer Immunology, Immunotherapy : CII|September 21, 2023
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinomaLisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, et al.Cancer Immunology, Immunotherapy : CII|September 27, 2023
A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinomaBanglun Pan, Yue Luo, Dongjie Ye, et al.Cancer Immunology, Immunotherapy : CII|October 2, 2024
Enhanced anti-tumor efficacy of electroporation (EP)-mediated DNA vaccine boosted by allogeneic lymphocytes in pre-established tumor modelsSanyuan Shi, Luchen Zhang, Anjie Zheng, et al.Cancer Immunology, Immunotherapy : CII|October 2, 2024
A random survival forest-based pathomics signature classifies immunotherapy prognosis and profiles TIME and genomics in ES-SCLC patientsYuxin Jiang, Yueying Chen, Qinpei Cheng, et al.Cancer Immunology, Immunotherapy : CII|October 2, 2024
Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphomaXinrui Chen, Yan Qin, Xuemin Xue, et al.Cancer Immunology, Immunotherapy : CII|October 2, 2024
Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer modelKi-Hyun Kim, Seung-Jae Kim, Jacob D Eccles, et al.Cancer Immunology, Immunotherapy : CII|September 13, 2024
Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapyJiao Xu, Bixin Yu, Fan Wang, et al.Pageof 651